Coltene Holding AGXSWX:CLTN -1.76%69 Return-on-Tangible-Equity is 23.86% as of Dec. 2025, which is 8% above its 10-year median of 22.02. GuruFocus rates XSWX:CLTN with a GF Score™ of 69/100 and a GF Value™ of CHF55.14 (Fairly Valued). The stock has 3 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Coltene Holding AG ranks better than 77.57% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Coltene Holding AG's annualized net income for the quarter that ended in Dec. 2025 was CHF21.4 Mil. Coltene Holding AG's average shareholder tangible equity for the quarter that ended in Dec. 2025 was CHF89.5 Mil. Therefore, Coltene Holding AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 23.86%.
The historical rank and industry rank for Coltene Holding AG's Return-on-Tangible-Equity or its related term are showing as below:
XSWX:CLTN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.38 Med: 22.02 Max: 33.53
Current: 15.9
During the past 13 years, Coltene Holding AG's highest Return-on-Tangible-Equity was 33.53%. The lowest was 9.38%. And the median was 22.02%.
XSWX:CLTN's Return-on-Tangible-Equity is ranked better than 77.57% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs XSWX:CLTN: 15.90
Coltene Holding AG (XSWX:CLTN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Coltene Holding AG Return-on-Tangible-Equity Related Terms
Coltene Holding AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coltene Holding AG Return-on-Tangible-Equity Chart
XSWX:CLTN vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.86% mean?
Coltene Holding AG (XSWX:CLTN) has a Return-on-Tangible-Equity of 23.86% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Coltene Holding AG and its competitors. This is near median its historical median of 22.02. Over the past decade, Coltene Holding AG's Return-on-Tangible-Equity has ranged from 9.38 to 33.53. According to the industry distribution chart, Coltene Holding AG ranks #170 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 22.4%.
Is Coltene Holding AG's Return-on-Tangible-Equity too high?
Coltene Holding AG's current Return-on-Tangible-Equity of 23.86% is near median its 10-year median of 22.02. Over the past 10 years, this metric has ranged from a low of 9.38 to a high of 33.53. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.08. Coltene Holding AG's value of 23.86% is 484.8% above this industry median. Based on the distribution chart, Coltene Holding AG ranks #170 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coltene Holding AG has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #170 out of 758 companies for Return-on-Tangible-Equity. This places Coltene Holding AG in the top 22% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.08. Coltene Holding AG's value of 23.86% is 484.8% above this benchmark. Historically, Coltene Holding AG's own Return-on-Tangible-Equity has ranged from 9.38 to 33.53 over the past decade. While the company's 10-year median is 22.02 vs. the industry median of 4.08, Coltene Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current Return-on-Tangible-Equity of 23.86% is 484.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current Return-on-Tangible-Equity is 23.86%, which is near median its own 10-year median of 22.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.14, compared to a current price of CHF50.10 — trading 9.1% below its estimated fair value. The current Return-on-Tangible-Equity is 23.86%, which is near median its 10-year median of 22.02 and 484.8% above the Medical Devices & Instruments industry median of 4.08. Coltene Holding AG's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current Return-on-Tangible-Equity is 23.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF50.10 is trading 9.1% below its estimated GF Value™ of CHF55.14.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
Return-on-Tangible-Equity: 23.86% (near median its 10-year median of 22.02)
GF Value™: CHF55.14 vs. price of CHF50.10 (9.1% below fair value)
Industry Position: 484.8% above the Medical Devices & Instruments median (#170 of 758)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
69GF Score
Get the complete analysis for XSWX:CLTN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
